May 12, 2026

This Week’s Biopharma News: Amgen Deepens US Manufacturing Push

The company adds $300 million to its Puerto Rico biologics site as Pfizer reports Phase 3 myeloma data, J&J advances a dual-pathway IBD antibody, and BioNTech streamlines production

The Medicine Maker

May 12, 2026

Ancient DNA Tracks 10,000 Years of Selection

Large dataset shows widespread genetic changes shaping modern traits and disease risk

The Pathologist

May 11, 2026

The Next Frontier in Wet AMD

AI-driven therapy planning is turning OCT from a monitoring tool into a forecasting engine for retina specialists

The Ophthalmologist

May 11, 2026

New Research Sheds Light on How Precancerous Lesions Form in the Pancreas

Discoveries about two metabolic enzymes could point the way to biomarkers, opportunities to prevent cancer.

Roswell Park Comprehensive Cancer Center

May 11, 2026

How Social Contact Shapes Gut Microbes

Cooperative behavior linked to shared anaerobic gut bacteria

The Pathologist

May 08, 2026

Frontline Pharma: Sarah O’Keeffe

Ahead of HPLC 2026, Eli Lilly’s Sarah O’Keeffe reflects on leadership, collaboration, and the analytical advances helping bring increasingly complex medicines to patients

The Analytical Scientist

May 08, 2026

Phase 3 Win for TED Therapy

Amgen’s subcutaneous TEPEZZA meets phase 3 endpoints in thyroid eye disease

The Ophthalmologist

May 06, 2026

Bridging the Gap Between Untargeted and Quantitative MS

Gary Siuzdak explains how his uMRM workflow could remove one of metabolomics’ biggest bottlenecks

The Analytical Scientist

May 06, 2026

Roving Reporter Asks: Where Do You See the Most Progress in CGT Manufacturing and Scalability?

IBTV speaks with industry leaders at the 2025 Meeting on the Mesa to explore advances in scaling cell and gene therapies

The Medicine Maker

May 05, 2026

Medical Oddities: Brain Health, Sunny-Side Up

Breakfast, bacteria, and brain wiring—small things show big implications this week.

Conexiant